RxDoctor Payments Data

Lisa Sytsma

Family Health · Colfax, IANPI 1770937682

Payments from drug & device makers

$435in general payments, 2019–2025

Across 29 payments — averaging $14.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$111
  • Boehringer Ingelheim$90
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$78
  • AbbVie$67
  • Novartis$43
  • Biohaven Pharmaceuticals, Inc.$18
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$435100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few family health providers in Iowato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$198,222
Medicare patients
191
Services billed
2,227

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Morphine Sulfate36$402
Tramadol Hcl18$399
Donepezil Hcl15$201
Hydromorphone Hcl13$178
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$168
Alprazolam12$99

Paid to pharmacies, not to this prescriber.

Other family health in Colfax

Where these figures come from

Is this you, or does something look wrong? →